Latest PostTraditional paper-based CSV processes are increasingly inefficient, time-consuming, and difficult to manage. Here's how paperless test execution and digital CSV solutions are changing the game for pharma validation teams.
Read More →
Manual CSV processes leave room for missed requirements, inconsistent documentation, and compliance gaps. Here's how AI-powered validation is changing that — and what GoVal does differently.
Read More →
CQV is not one process — it's three distinct phases that work together to ensure pharma facilities, systems, and equipment consistently produce safe, compliant products. Here's how they differ and why each matters.
Read More →
Unscripted testing is one of CSA's most misunderstood tools. It's not informal testing — it's structured exploratory testing with a documented rationale. Here's when it applies and how to make it inspection-ready.
Read More →
An FDA Warning Letter isn't the end — but your 15-day response determines whether it resolves or escalates. Here's what triggers them in validation and how to respond effectively.
Read More →
Operating across the US and EU means satisfying two different electronic records frameworks simultaneously. Here's exactly where EU Annex 11 and 21 CFR Part 11 differ — and where they align.
Read More →
Paper-based validation creates audit risk, FTE overhead, and data integrity gaps that most teams underestimate. Here's what paperless validation actually delivers — and the practical steps to get there.
Read More →
A risk-based validation approach isn't about cutting corners. It's about directing rigour where it actually protects patients — and reducing overhead where it doesn't. Here's how to do it in practice.
Read More →
Excel, Word, and SharePoint weren't built for GxP validation. Here's what that actually costs you — in audit risk, data integrity gaps, and compliance overhead — and what purpose-built validation software changes.
Read More →
The FDA finalised its Computer Software Assurance guidance in September 2025. Here's what changed, what stayed the same, and what your validation programme needs to do differently starting now.
Read More →
CSA isn't just 'less CSV.' It's a fundamentally different way of thinking about software validation in GxP environments. Here's what it actually means — without the regulatory jargon.
Read More →
ALCOA++ isn't a name change — it adds three new principles that shift data integrity from document control to system-level assurance. Here's what changed and what your validation platform needs to handle.
Read More →
Cleaning validation proves your equipment cleaning procedures consistently remove residues to safe, pre-defined levels. Here's what regulators require, how to set HBEL-based acceptance criteria, and where most facilities still get it wrong.
Read More →
Paper validation consumes over 20% of project budgets and produces audit trails inspectors routinely challenge. The ROI of going paperless is documented — here's what the numbers show.
Read More →
Biotech validation is faster, more complex, and under more regulatory scrutiny than ever. Here's what your validation platform needs to handle — and where generic tools fall short.
Read More →
With FDA CSA guidance finalised in September 2025, choosing the right VLMS has never been more consequential. This guide covers what matters in 2026 — and why GoVal is purpose-built to lead on every criterion that counts.
Read More →
A VLMS maintains a continuous, current record of the validation state of every GxP system in your environment. Without one, the gap between the compliance state you believe you're in and the state you're actually in becomes visible only when an inspector arrives.
Read More →
Equipment validation is inspection-scrutinised for one reason: the ongoing programme is harder to maintain than the initial qualification. This guide covers IQ, OQ, and PQ — and more critically, the change control, calibration, and periodic review programme that keeps equipment in a validated state.
Read More →
Digital validation software promises faster cycles and easier audits. The platforms that deliver on that promise share five specific characteristics. The ones that don't share one: they digitise your existing paper process and call it transformation.
Read More →
Not all computer system validation software is equal. Some are purpose-built VLMS platforms. Others are document management tools with a pharma marketing layer. This guide shows you how to tell the difference — and exactly what the gaps cost you in inspection findings.
Read More →
FDA's CSA guidance finalised September 2025 changed how pharma teams validate MES, QMS, and LIMS. Most teams still apply the old CSV approach to everything. Here is exactly what CSA means for your production and quality software in 2026.
Read More →
IQ, OQ, and PQ are the three qualification phases every pharma validation team executes — but FDA 483 observations show the same six gaps recurring in qualification packages across the industry. This guide covers what each phase requires and exactly which mistakes to avoid.
Read More →
The FDA cited Part 11 gaps in over 30% of pharma software inspections in 2025. Use this checklist to find every gap in your audit trails, e-signatures, and access controls before an inspector does.
Read More →
GAMP 5 tells you to match validation effort to software risk — but which category does your LIMS, ERP, or custom automation script actually fall under? Every category explained with 2026 pharma software examples and exactly what validation each requires.
Read More →
CSV and CSA both aim for compliant software — but differ fundamentally in philosophy, effort, and risk approach. Here is what every pharma and life sciences team needs to understand before choosing one.
Read More →.jpg)
Master GxP compliance across diverse Life Sciences sectors. Learn how a unified validation platform streamlines biotechnology validation, medical device validation, and clinical trial validation with tailored, risk-based workflows.
Read More →
Learn how a hybrid validation deployment blends traditional CSV with modern CSA. Discover how GoVal's VLMS enables a flexible, risk-based approach with configurable workflows, dynamic risk assessment, and adaptable testing protocols.
Read More →
What validation debt is and how GoVal’s VLMS and AI reduce it—automated traceability, evidence capture, e-signatures, and risk-based testing aligned with 21 CFR Part 11 & EU Annex 11.
Read More →
Learn how paperless validation, electronic records, and audit trails ensure 21 CFR Part 11 compliance.
Read More →
In the dynamic landscape of the life sciences industry, ensuring the quality and compliance of computer systems is paramount. Traditional validation processes are time-consuming and error-prone.
Read More →
Implementing a paperless validation solution is crucial for modern life science organizations seeking to streamline GxP compliance and enhance efficiency. This article outlines a smart, risk-based approach to ensure a successful transition to digital validation, optimizing your validation lifecycle management (VLMS).
Read More →
In the world of computer system validation (CSV), efficient test case management is paramount. Manual processes are often riddled with delays and inconsistencies.
Read More →
In the fast-paced world of life sciences, the transition from paper to digital validation is no longer optional. It’s essential for maintaining audit readiness.
Read More →
In the demanding pharma and life sciences sectors, robust computer system validation is essential for compliance and efficiency. GoVal simplifies the process.
Read More →
Kneat is strong on protocol execution, but life sciences teams that need built-in AI, risk-based CSV, and transparent pricing are switching to GoVal. Here's a feature-by-feature breakdown.
Read Comparison →
ValGenesis dominates the enterprise VLMS space — but its licensing complexity and implementation timelines leave mid-sized pharma and biotech teams underserved. See how GoVal compares.
Read Comparison →
MasterControl is a QMS platform with validation bolted on. GoVal is a purpose-built VLMS — every feature engineered for validation. Get deeper compliance, AI automation, and up to 60% lower cost.
Read Comparison →